Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Align Technology
ALGN
|
+$420M |
| 2 |
Walt Disney
DIS
|
+$412M |
| 3 |
Deere & Co
DE
|
+$405M |
| 4 |
Icon
ICLR
|
+$400M |
| 5 |
Freeport-McMoran
FCX
|
+$276M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$972M |
| 2 |
Amazon
AMZN
|
+$636M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$391M |
| 4 |
Microsoft
MSFT
|
+$380M |
| 5 |
Aon
AON
|
+$316M |
Sector Composition
| 1 | Technology | 30.67% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Idexx Laboratories
IDXX
$51.6B
| $21.6M | 0.01% |
34,660
-6,127
| -15% | -$3.81M |
|
|
ABCM
777
DELISTED
Abcam plc American Depositary Shares
ABCM
| $21.1M | 0.01% |
1,041,353
+42,371
| +4% | +$859K |
|
778
Duke Energy
DUK
$95B
| $21.1M | 0.01% |
215,769
+55,461
| +35% | +$5.41M |
|
779
Fox Class A
FOXA
$28.7B
| $21M | 0.01% |
524,155
-287,739
| -35% | -$11.5M |
|
780
Cogent Biosciences
COGT
$1.79B
| $21M | 0.01% |
2,493,961
+55,760
| +2% | +$469K |
|
781
US Bancorp
USB
$76.8B
| $21M | 0.01% |
352,940
-121,657
| -26% | -$7.23M |
|
782
Franklin FTSE Japan ETF
FLJP
$2.4B
| $21M | 0.01% |
678,736
+82,633
| +14% | +$2.55M |
|
783
Novo Nordisk
NVO
$241B
| $20.9M | 0.01% |
436,292
+9,256
| +2% | +$444K |
|
784
Marqeta
MQ
$2.68B
| $20.9M | 0.01% |
946,750
-653,194
| -41% | -$14.4M |
|
785
Weyerhaeuser
WY
$18.6B
| $20.8M | 0.01% |
585,231
+266,007
| +83% | +$9.46M |
|
|
AMK
786
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $20.8M | 0.01% |
836,200
-6,125
| -0.7% | -$152K |
|
787
Skechers
SKX
$9.49B
| $20.7M | 0.01% |
491,258
+168,059
| +52% | +$7.08M |
|
788
Axogen
AXGN
$773M
| $20.6M | 0.01% |
1,305,376
-8,796
| -0.7% | -$139K |
|
789
Cadence Bank
CADE
$6.96B
| $20.5M | 0.01% |
+689,739
| New | +$20.5M |
|
790
Schlumberger
SLB
$53.8B
| $20.5M | 0.01% |
691,927
-89,076
| -11% | -$2.64M |
|
|
RAIN
791
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $20.5M | 0.01% |
1,402,074
-50,541
| -3% | -$737K |
|
792
TJX Companies
TJX
$157B
| $20.3M | 0.01% |
308,034
+4,478
| +1% | +$295K |
|
793
Manchester United
MANU
$2.76B
| $20.3M | 0.01% |
1,046,840
-9,970
| -0.9% | -$193K |
|
794
IAC Inc
IAC
$2.95B
| $20.2M | 0.01% |
189,197
-30,088
| -14% | -$3.22M |
|
|
TIG
795
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $20.1M | 0.01% |
1,940,493
+743,949
| +62% | +$7.7M |
|
796
Equifax
EFX
$32.1B
| $20M | 0.01% |
78,826
-3,724
| -5% | -$944K |
|
797
Surmodics
SRDX
$461M
| $19.9M | 0.01% |
358,424
-1,557
| -0.4% | -$86.6K |
|
798
KalVista Pharmaceuticals
KALV
$746M
| $19.9M | 0.01% |
1,141,683
-27,917
| -2% | -$487K |
|
799
AST SpaceMobile
ASTS
$10.3B
| $19.8M | 0.01% |
1,832,761
-297
| -0% | -$3.21K |
|
800
Anika Therapeutics
ANIK
$124M
| $19.7M | 0.01% |
463,785
+259,147
| +127% | +$11M |
|